#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	19546	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2085	927.6	0	.	n	.	0	C451T	SNP	451	451	C	684	684	T	1083	T,C,G	791,254,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	19546	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2085	927.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1417	1417	C	1168	C	1138	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35890	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3432	1038.0	0	.	n	.	0	T695C	SNP	695	695	T	985	985	C	1074	C,T	1054,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35890	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3432	1038.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2261	2261	C	1085	C,T	1053,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35890	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3432	1038.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2335	2335	A	1121	A	1103	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35890	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3432	1038.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2887	2887	C	1049	C	1017	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35890	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3432	1038.0	0	HET	.	.	.	C539T,G	.	539	539	C	829	829	C	1209	C,T,G	889,263,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2466	folP	855	855	100.0	folP.l6.c4.ctg.1	1575	156.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1033	1035	AGC	248;247;247	A;G;C	243;242;239	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7116	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3409	207.0	1	SNP	p	S91F	1	.	.	271	273	TTC	655	657	TTC	263;265;262	T;T,C;C	255;257,1;252	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7116	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3409	207.0	1	SNP	p	G95N	0	.	.	283	285	GGC	667	669	GGC	258;258;258	G;G,A;C	252;252,1;249	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7116	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3409	207.0	1	SNP	p	D95G	1	.	.	283	285	GGC	667	669	GGC	258;258;258	G;G,A;C	252;252,1;249	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2322	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1339	171.9	1	SNP	p	G45D	0	.	.	133	135	GGC	444	446	GGC	287;281;285	G,T;G,T;C	279,1;272,1;276	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1126	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1030	107.5	0	.	n	.	0	A197.	DEL	197	197	A	532	532	A	266	A	260	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2791	230.4	1	SNP	p	D86N	0	.	.	256	258	GAC	492	494	GAC	259;257;259	G;A;C	250;240;249	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2791	230.4	1	SNP	p	S87R	1	.	.	259	261	CGT	495	497	CGT	256;256;263	C;G;T	248;245;250	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2791	230.4	1	SNP	p	R87I	0	.	.	259	261	CGT	495	497	CGT	256;256;263	C;G;T	248;245;250	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2791	230.4	1	SNP	p	R87W	0	.	.	259	261	CGT	495	497	CGT	256;256;263	C;G;T	248;245;250	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6484	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2791	230.4	1	SNP	p	S88P	0	.	.	262	264	TCC	498	500	TCC	261;264;263	T;C;C	252;254;252	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5694	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2599	217.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1465	1467	GGC	297;295;292	G;G,T;C	281;278,1;277	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1280	1282	GCC	291;293;292	G;C;C	283;284;285	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1283	1285	ATG	293;293;292	A;T;G,T	289;286;283,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1295	1297	ACC	291;290;287	A;C;C	282;288;280	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1295	1297	ACC	291;290;287	A;C;C	282;288;280	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1796	1798	ACC	244;243;248	A;C;C	231;240;244	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1850	1852	GCG	241;244;247	G;C;G	232;237;240	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1850	1852	GCG	241;244;247	G;C;G	232;237;240	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1973	1975	GGT	200;200;198	G;G;T	191;191;184	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1982	1984	AGC	176;173;172	A;G;C,G	169;168;166,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5394	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2382	224.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2000	2002	CCG	152;152;154	C,G;C,G;G	130,4;136,2;135	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7586	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	2963	254.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1526	1528	CCG	280;278;279	C,G;C;G,C	244,1;268;254,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3232	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1633	194.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	486	486	C	212	C	200	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3556	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1415	245.9	0	.	p	.	0	G210R	NONSYN	628	630	GGA	884	886	AGA	301;303;298	A;G;A	295;291;292	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3556	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1415	245.9	0	.	p	.	0	S217G	NONSYN	649	651	AGT	905	907	GGT	278;278;274	G,A;G;T,C	265,3;272;260,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3556	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1415	245.9	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1010	1012	GAA	245;245;248	G;A,G;A,C	239;236,2;240,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3556	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1415	245.9	1	SNP	p	G120K	1	.	.	358	360	AAG	614	616	AAG	262;260;262	A,G,C;A,G;G,T,A	245,2,1;251,2;237,2,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3556	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1415	245.9	1	SNP	p	N121D	0	.	.	361	363	AAC	617	619	AAC	267;270;270	A,G;A,C;C	256,2;260,2;258	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3556	porB1b	1038	1038	99.71	porB1b.l15.c17.ctg.1	1415	245.9	1	SNP	p	A121N	1	.	.	361	363	AAC	617	619	AAC	267;270;270	A,G;A,C;C	256,2;260,2;258	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12922	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4777	268.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1464	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1105	131.4	1	SNP	p	V57M	1	.	.	169	171	ATG	463	465	ATG	271;273;271	A;T;G	262;265;261	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
